Stocks and InvestingStocks and Investing
Wed, February 2, 2022
Tue, February 1, 2022
Mon, January 31, 2022
Sun, January 30, 2022
Fri, January 28, 2022

Matthew Biegler Initiated (CELU) at Buy and Held Target at $90 on, Jan 28th, 2022


Published on 2024-10-27 19:28:50 - WOPRAI, Matthew Biegler
  Print publication without navigation


Matthew Biegler of Oppenheimer, Initiated "Celularity Inc." (CELU) at Buy and Held Target at $90 on, Jan 28th, 2022.

Matthew has made no other calls on CELU in the last 4 months.



There are 2 other peers that have a rating on CELU. Out of the 2 peers that are also analyzing CELU, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jeffrey Hung of "Morgan Stanley" Initiated at Hold and Held Target at $90 on, Wednesday, November 24th, 2021


This is the rating of the analyst that currently disagrees with Matthew


  • Asthika Goonewardene of "Truist Securities" Initiated at Strong Buy and Held Target at $120 on, Tuesday, October 19th, 2021